Abstract:Breast cancer is a serious threat to human health. The transforming growth factor-β signaling pathway is an important pathway involved in the occurrence and development of cancer. The SMAD family genes are responsible for the TGF-β signaling pathway. However, the mechanism by which genes of the SMAD family are involved in breast cancer is still unclear. Therefore, it is necessary to investigate the biological roles of the SMAD family genes in breast cancer. We downloaded the gene expression data, gene mutation data, and clinical pathological data of breast cancer patients from the UCSC Xena database. We used the Wilcox test to estimate the expression of genes of the SMAD family in cancers. And the biological functions of SMAD family genes using the DAVID website. The Pearson correlation method was used to explore the immune cell infiltration and drug response of SMAD family genes. We conducted in biological experiments vitro and vivo. In this study, we integrated the multi-omics data from TCGA breast cancer patients for analysis. The expression of genes of SMAD family was significantly dysregulated in patients with breast cancer. Except for SMAD6, the expression of other SMAD family genes was positively correlated. We also found that genes of the SMAD family were significantly enriched in the TGF-β signaling pathway, Hippo signaling pathway, cell cycle, and cancer-related pathways. In addition, SMAD3, SMAD6, and SMAD7 were lowly expressed in stage II breast cancer, while SMAD4 and SMAD2 were lowly expressed in stage III cancer. Furthermore, the expression of genes of the SMAD family was significantly correlated with immune cell infiltration scores. Constructing a xenograft tumor mouse model, we found that SMAD3 knockdown significantly inhibited tumorigenesis. Finally, we analyzed the association between these genes and the IC50 value of drugs. Interestingly, patients with high expression of SMAD3 exhibited significant resistance to dasatinib and staurosporine, while high sensitivity to tamoxifen and auranofin. In addition, SMAD3 knockdown promoted the apoptosis of BT-549 cells and decreased cell activity, and BAY-1161909 and XK-469 increased drug efficacy. In conclusion, genes of the SMAD family play a crucial role in the development of breast cancer.

Global isonicotinylome analysis identified SMAD3 isonicotinylation promotes liver cancer cell epithelial-mesenchymal transition and invasion

Biphasic Reduction of Histone H3 Phosphorylation in Response to N-nitroso Compounds Induced DNA Damage

Isonicotinylation is a Histone Mark Induced by the Anti-Tuberculosis First-Line Drug Isoniazid.

SUMOylated NICD in Endothelial Cell Suppresses Tumor Angiogenesis

Advancements in Tyrosine Kinase-Mediated Regulation of Innate Nucleic Acid Sensing.

Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-β signaling

Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-beta signaling.

KMT5A-methylated SNIP1 promotes triple-negative breast cancer metastasis by activating YAP signaling

SIRT1 ISGylation accelerates tumor progression by unleashing SIRT1 from the inactive state to promote its deacetylase activity

Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway.

Suppression of nuclear GSK3 signaling promotes serine/one-carbon metabolism and confers metabolic vulnerability in lung cancer cells

Sulfopin, a selective covalent inhibitor of Pin1, blocks Myc-driven tumor initiation and growth<i>in vivo</i>

PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest

The immune regulation and therapeutic potential of the SMAD gene family in breast cancer

Histone Methyltransferase KMT5C Drives Liver Cancer Progression and Directs Therapeutic Response to PARP Inhibitors.

SNIP 1 Recruits TET 2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response

Go-Ichi-Ni-San 2: A Potential Biomarker and Therapeutic Target in Human Cancers.

Nicotinic acid suppresses liver cancer metastasis via histone lysine nicotinylation

INPP4B is an Oncogenic Regulator in Human Colon Cancer.

Nuclear IL‐33/SMAD signaling axis promotes cancer development in chronic inflammation

Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesis